Neuroendocrine carcinomas of the lung and role of ¹¹¹In-DTPA-octreotide scintigraphy: Preliminary results

The authors report their experience on the use of ¹¹¹In-DTPA-octreotide scintigraphy in the diagnosis of neuroendocrine carcinomas of the lung. The studies were performed both preoperatively, to obtain a correct staging of the tumor, or postoperatively, because of the suspicion of a recurrence or distant metastases. The main findings were: high sensitivity in localizing the tumor and its recurrences or metastases and high predictive value for responsiveness to "cold" octreotide therapy.